← Eichor
Study identifier: NCT06447064 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Cancer Loyalty Card Study 2 (CLOCS-2)

Condition: Pancreatic Cancer · Colon Cancer · Oesophageal Cancer  ·  Sponsor: Imperial College London

PhaseN/A
Planned participants2900
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

Cancer is one of the leading causes of mortality worldwide and is responsible for an estimated 9.6 million deaths yearly. Cancer-related deaths can be reduced if patients are diagnosed and treated early. Delay in cancer diagnosis can occur at any point along the diagnostic spectrum, from the first observation of symptoms to the start of treatment. Diagnosing cancer when it is still at an early stage, before it has spread, gives surgery, radiotherapy and other treatments the best chance of working. Therefore, early diagnosis is the most important way to improve cancer outcomes.Most of the cancers usually presents with vague and non-alarming symptoms. Most individuals are diagnosed late when the cancer has already spread, and the prognosis is poor. There are over 200 different types of cancer that can cause many different signs and symptoms. Sometimes symptoms affect specific body areas, such as abdomen or skin. But signs can also be more general, and include weight loss, tiredness (fatigue) or unexplained pain. The type of symptoms varies from person to person. The major reasons for not presenting to the GP with symptoms such as these are "not wanting to waste the GP's time" and normalisation of these symptoms. The persistence of a symptom, social influence and awareness encourage help-seeking behaviours in primary care. However, few believe their symptom(s) might be a sign of cancer. Consequently, people might choose to self-manage their symptoms by using over-the-counter …

This description comes directly from the study's public registry record.

Talk to the study team

Yuscah Pondeca  ·  02075942127  ·  yuscah.pondeca16@imperial.ac.uk

Dr James Flanagan  ·  02075942127  ·  j.flanagan@imperial.ac.uk

Always discuss trial participation with your own doctor first.

Locations (1)

Imperial College Healthcare NHS TrustLondon, United KingdomRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06447064